Evidence map›Paper›PMID 29134489›Full record

Observational studyInternational journal of clinical pharmacy2018

The quick loss of carbapenem susceptibility in Pseudomonas aeruginosa at intensive care units.

Yamin Zou, Jiangping Lian, Ying Di, Haisheng You, Hongping Yao, Junhui Liu, Yalin Dong

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in International journal of clinical pharmacy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The prognostic value of neutrophil-to-lymphocyte ratio in adult carbapenem-resistantFrontiers in cellular and infection microbiology · 2024
    Article
  2. Risk factors and outcome associated with coinfection with carbapenem-resistantFrontiers in cellular and infection microbiology · 2023
    Article
  3. Carbapenem ResistantInfection and drug resistance · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yamin ZouDepartment of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Jiangping LianDepartment of Pharmacy, Shaanxi Provincial People's Hospital, Xi'an, China.
Ying DiSurgical Intensive Care Unit, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Haisheng YouDepartment of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Hongping YaoDepartment of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Junhui LiuDepartment of Clinical Laboratory, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yalin DongDepartment of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. dongyalin@mail.xjtu.edu.cn.

Funding

Shaanxi Provincial Natural Science Foundation 2016JM8015the National Natural Science Foundation of China 81473177the National Natural Science Foundation of China 81672954
6 · The paper itself

Abstract

Background Patients colonized with carbapenem-susceptible Pseudomonas aeruginosa (CSPA) strains upon admission to the intensive care unit (ICU) tend to be quickly followed by detected carbapenem-resistant P. aeruginosa strains after admission. Objective To assess the risk factors associated with the quick loss of carbapenem susceptibility and to identify time threshold of prior antimicrobial exposure for the loss during ICU stay. Setting A tertiary-care teaching hospital with 2560 beds located in the northwest region of China. Method A retrospective observational study was conducted between January 2013 and April 2016 at ICUs. Logistic regression analysis was used to assess risk factors, and receiver operating characteristic (ROC) analyses were constructed to identify the time threshold. Main outcome measure The time threshold and risk factors for the quick loss of carbapenem susceptibility. Results Among the 84 patients with CSPA initially, 32 (38.1%) patients were observed to have a loss of carbapenem susceptibility during ICU stay. Logistic regression analyses showed that previous carbapenem exposure was only independently associated with the loss of carbapenem susceptibility (odds ratio 13.16; 95% CI 3.13-55.24; p < 0.001). The optimal cut-off was 3.5 days on ROC curve, indicating the high risk for loss of susceptibility. Conclusion In order to alleviate selective pressure caused by antipseudomonal carbapenems exposure, continued research is needed to determine the most appropriate carbapenems treatment strategies.

Indexed as

AdultAgedAnti-Bacterial AgentsCarbapenemsDrug Resistance, BacterialFemaleHumansIntensive Care UnitsMaleMiddle AgedPseudomonas aeruginosaPseudomonas InfectionsRetrospective StudiesRisk FactorsTime FactorsAnti-Bacterial AgentsCarbapenemsAntibiotics resistanceCarbapenemChinaIntensive careTime thresholdTreatment strategy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.